Skip to main content

Table 2 CML/CLL/ALL Case Description (n = 9)

From: Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005

Age at dx

Disease stage at dx

Chemotherapy

Radiation

Leukemia Type

Time from breast dx to leukemia (months)

Time from leukemia

dx to last fu (months)

79

I

none

yes

CLL

37

57 (Alive)

64

I

none

yes

CLL

61

56 (Dec.)

74

I

none

yes

CLL

96

20 (Alive)

61

II

None

no

CLL

79

109 (Alive)

58

I

None

yes

CLL

110

70 (Alive)

50

I

recurrence 1993

yes

CML

33

9 (Dec.)

73*

I

None

yes

CML

3

14 (Dec.)

76

II

None

yes

ALL

38

19 (Dec.)

81

I

None

yes

ALL

81

4 (Dec.)

  1. * Cytogenetics: Philadelphia chromosome resulting from a 9;22 translocation designated as 46, XX, t(9;22)(q34;q11 2).